Frentizole derivatives with mTOR inhibiting and senomorphic properties
Jazyk angličtina Země Francie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
37783152
DOI
10.1016/j.biopha.2023.115600
PII: S0753-3322(23)01398-7
Knihovny.cz E-zdroje
- Klíčová slova
- ABAD, Aging, Cellular senescence, Frentizole, MTOR,
- MeSH
- Alzheimerova nemoc * MeSH
- amyloidní beta-protein * metabolismus MeSH
- imunosupresiva MeSH
- léky proti stárnutí MeSH
- myši MeSH
- sirolimus MeSH
- TOR serin-threoninkinasy MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- amyloidní beta-protein * MeSH
- frentizole MeSH Prohlížeč
- imunosupresiva MeSH
- léky proti stárnutí MeSH
- sirolimus MeSH
- TOR serin-threoninkinasy MeSH
Frentizole is immunosuppressive drug with low acute toxicity and lifespan-prolonging effect. Recently, frentizole´s potential to disrupt toxic amyloid β (Aβ) - Aβ-binding alcohol dehydrogenase (ABAD) interaction in mitochondria in Alzheimer´s brains has been revealed. Another broadly studied drug with anti-aging and immunosuppressive properties is an mTOR inhibitor - rapamycin. Since we do not yet precisely know what is behind the lifespan-prolonging effect of rapamycin and frentizole, whether it is the ability to inhibit the mTOR signaling pathway, reduction in mitochondrial toxicity, immunosuppressive effect, or a combination of all of them, we have decided within our previous work to dock the entire in-house library of almost 240 Aβ-ABAD modulators into the FKBP-rapamycin-binding (FRB) domain of mTOR in order to interlink mTOR-centric and mitochondrial free radical-centric theories of aging and thus to increase the chances of success. Based on the results of the docking study, molecular dynamic simulation and MM-PBSA calculations, we have selected nine frentizole-like compounds (1 - 9). Subsequently, we have determined their real physical-chemical properties (logP, logD, pKa and solubility in water and buffer), cytotoxic/cytostatic, mTOR inhibitory, and in vitro anti-senescence (senolytic and senomorphic) effects. Finally, the three best candidates (4, 8, and 9) have been forwarded for in vivo safety studies to assess their acute toxicity and pharmacokinetic properties. Based on obtained results, only compound 4 demonstrated the best results within in vitro testing, the ability to cross the blood-brain barrier and the lowest acute toxicity (LD50 in male mice 559 mg/kg; LD50 in female mice 575 mg/kg).
Faculty of Chemistry University of Belgrade Studenski trg 16 11000 Belgrade Serbia
Special Police Unit Ministry of Interior Trebevićka 12 A 11030 Belgrade Serbia
Zoology Department College of Science King Saud University Riyadh 11451 Saudi Arabia
Citace poskytuje Crossref.org